Galixir
PrivateLast Round
VC Round
Aug 4, 2021
Total Funding Raised
$10M
Company Overview
Galixir is a biotechnology company that leverages artificial intelligence to accelerate preclinical drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Galixir Comparables
Compare Galixir with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MindRank | 91% | |
| StoneWise | 88% | |
| Genesis Molecular AI | 85% | |
Galixir Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 4, 2021 | ||||
| Series A Extension | Dec 29, 2020 | ||||
| Series A | Sep 1, 2020 | ||||
| Pre Seed | Aug 17, 2020 | ||||
| Angel | Nov 1, 2019 |
Key People
Founding team and executive leadership
Galixir Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCM Ventures | Series A Extension, Series A, VC Round, Pre Seed |
| 5Y Capital | VC Round, Pre Seed, Series A Extension, Series A |
| Source Code Capital | Series A Extension, Series A, VC Round, Pre Seed |
| ACE Redpoint Ventures | VC Round, Series A Extension, Series A |
| BAI Capital | Series A Extension, Series A, VC Round |
| Gaorong Capital | Angel, Series A Extension, Series A, VC Round, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2020
Led by 5Y Capital and ACE Redpoint Ventures.
Galixir Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Galixir's valuation, stock price, and market status.